참고문헌
- Amirkhosravi A, Meyer T, Amaya M, et al (2007). The role of tissue factor pathway inhibitor in tumor growth and metastasis. Semin Thromb Hemost, 33, 643-52. https://doi.org/10.1055/s-2007-991531
- Boudny V, Vrana O, Gaucheron F, et al (1992). Biophysical analysis of DNA modified by 1, 2-diaminocyclohexane platinum (II) complexes. Nucleic Acids Res, 20, 267-72. https://doi.org/10.1093/nar/20.2.267
- Camerer E, Rottingen JA, Gjemes E, et al (1999). Coagulation factors VIIa and Xa induce cell signaling leading to up regulation of the egr-1 gene. J Biol Chem, 274, 32225-33. https://doi.org/10.1074/jbc.274.45.32225
- Carrier M, Le Gal G, Wells PS, et al (2008). Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism? Ann Intern Med, 149, 323-33. https://doi.org/10.7326/0003-4819-149-5-200809020-00007
- Donati MB (1994). Cancer and thrombosis. Haemostasis, 24, 128-31.
- Forster Y, Meye A, Albrecht S, Schwenzer B (2006). Tissue factor and tumor: clinical and laboratory aspects. Clin Chim Acta, 364, 12-21. https://doi.org/10.1016/j.cca.2005.05.018
- Gallus AS (1997). Prevention of post-operative deep leg vein thrombosis in patients with cancer. Thromb Haemost, 78, 126-32.
- Gomes MP, Deitcher SR (2003). Diagnosis of venous thromboembolic disease in cancer patients. Oncology (Williston Park), 17, 126-35.
- Jiao ZY, Gou CZ, Cao N, Li YM (2005). Correlation of tissue factor expression to angiogenesis of gastric carcinoma and its clinical significance. Chin J Cancer, 24, 880-4.
- Kakkar AK, DeRuvo N (1995). Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor. Lancet, 346, 1004-5. https://doi.org/10.1016/S0140-6736(95)91690-3
- Khorana AA, Francis CW, Culakova E, et al (2007). Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost, 5, 632-4. https://doi.org/10.1111/j.1538-7836.2007.02374.x
- Kollmannsberger C, Quietzsch D, Haag C, et al (2000). A phase II study of paclitaxel, weekly, 24-hour continous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer. Br J Cancer, 83, 458-62. https://doi.org/10.1054/bjoc.2000.1295
- Lykke J, Nielsen HJ (2003). The role oftissue factor in eolorcctal cancer. Eur J Surg Oneol, 29, 417-22. https://doi.org/10.1016/S0748-7983(03)00053-2
- Manly DA, Wang J, Glover SL, et al (2010). Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism. Thromb Res, 125, 511-2 https://doi.org/10.1016/j.thromres.2009.09.019
- Mueller BM, Reisfeld RA, Edgington TS, Ruf W (1992). Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc Natl Acad Sci U S A, 89, 11832-6. https://doi.org/10.1073/pnas.89.24.11832
- Nakasaki T, Wada H, Shigemori C, et al (2002). Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer. Am J Hematol, 69, 247-54. https://doi.org/10.1002/ajh.10061
- Nitori N, Ino Y, Nakanishi Y, et al (2005). Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma. Clin Cancer Res, 11, 2531-9. https://doi.org/10.1158/1078-0432.CCR-04-0866
- Prandoni P, Piccioli A (2006). Thrombosis as a harbinger of cancer. Curr Opin Hematol, 13, 362-5. https://doi.org/10.1097/01.moh.0000239709.47921.04
- Rao LV, Pendurthi UR (2005). Tissue factor-factor VIIa signaling. Arterioscler Thromb Vasc Biol, 25, 47-56.
- Raymond E, Faivre S, Woynarowski JM, Chaney SG (1998). Oxaliplatin: mechanism of action and antineoplastic activity. Semin Oncol, 25, 4-12.
- Sorensen BB, Rao LV, Tornehave D, Gammeltoft S, Petersen LC (2003). Antiapoptotic efect of coagulation factorVIIa. Blood, 102, 1708-15. https://doi.org/10.1182/blood-2003-01-0157
- Toomey JR, Kratzer KE, Lasky NM, Broze GJ Jr (1997). Effect of tissue factor deficiency on mouse and tumor development. Proc Natl Acad Sci U S A, 94, 6922-6. https://doi.org/10.1073/pnas.94.13.6922
- Versteeg HH, Spek CA, Richel DJ, Peppelenbosch MP (2004). Coagulation factorsVIIa and Xa inhibit apoptosis and anoikis. Oncogene, 23, 410-7. https://doi.org/10.1038/sj.onc.1207066
- Yamashita H, Kitayama J, Ishikawa M, Nagawa H (2007). Tissue factor expression is a clinical indicator of lymphatic metastasis and poor prognosis in gastric cancer With intestinal phenotype. J Surg Oncol, 95, 324-31. https://doi.org/10.1002/jso.20680
피인용 문헌
- Tissue factor in tumor microenvironment: a systematic review vol.7, pp.1, 2014, https://doi.org/10.1186/s13045-014-0054-8
- Effect of tissue factor knockdown on the growth, invasion, chemoresistance and apoptosis of human gastric cancer cells vol.7, pp.5, 2014, https://doi.org/10.3892/etm.2014.1591
- Anticancer effect of cucurbitacin B on MKN-45 cells via inhibition of the JAK2/STAT3 signaling pathway vol.12, pp.4, 2016, https://doi.org/10.3892/etm.2016.3670
- VEGF gene promoter polymorphisms and risk of VTE in chemotherapy-treated cancer patients vol.115, pp.01, 2016, https://doi.org/10.1160/TH15-03-0259